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In the presence of hypoglycaemia and liver dysfunction in the neonatal period and/or 
during the first months of life, a myriad aetiologies should be considered. We report herein 
the case of a child with refractory hypoglycaemia and severe liver dysfunction, highlighting 
the importance of a multidisciplinary and rapid investigation to obtain the final diagnosis.
A girl was born by emergent caesarean delivery at 37 weeks, due to a non-reassuring 
foetal state and maternal fever after a pregnancy complicated by insulin-treated gestational 
diabetes, de novo maternal hyperthyroidism without detectable thyrotropin (TSH) receptor 
antibody (TRAb), and intrauterine growth restriction. She was admitted to the Neonatal 
Intensive Care Unit because of feeding difficulties and hypoglycaemia, needing enteric 
nutrition by gavage for 48 h. Newborn screening was normal. After discharge, preterm 
formula was continued with weight evolution in the 3–10th percentile. At 2 months of life, she
presented vomiting, jaundice, pale stools, and refusal to feed and was admitted to the local 
hospital. On physical examination, she presented jaundice and peculiar facies (Fig. 1). 
Laboratory results were as follows: total bilirubin (TB) — 8.28 mg/dL, direct bilirubin (DB) 
— 6.76 mg/dL, aspartate aminotransferase (AST) — 194 U/L, alanine aminotransferase 
(ALT) — 93 U/L, gamma-glutamyl transferase (GGT) — 52 U/L, alkaline phosphatase 
(ALP) — 671 U/L, and glucose — 59 mg/dL. In the first 48 h, she started with fever, 
repeated episodes of hypoglycaemia (min. 35 mg/dL, nonketotic), vomiting, worsening 
clinical status, and persistent abnormal results: AST — 883 U/L, ALT — 266 U/L, TB — 
11.5 mg/dL, DB — 6.7 mg/dL, ALP — 678 U/L, GGT — 31 U/L, albumin — 31.7 g/L; 
activated partial thromboplastin time (APTT) — 66.8 s, partial thromboplastin time (PT) — 
26.6 s; C-reactive protein (CRP) — 82.6 mg/L; no electrolyte abnormalities; and alpha-1 
antitrypsin normal. She was admitted to the Intensive Care Unit, requiring high doses of 
glucose (glucose infusion rate max. 11 g/kg/min); fresh frozen plasma was also administered. 
Abdominal ultrasound showed normal liver, gallbladder without bile duct dilatation, and 
moderate ascites. Transfontanellar ultrasound revealed hyperechogenicity of basal 
ganglia/thalamus bilaterally. Due to the severity of the clinical presentation a simultaneous 
investigation for infectious, metabolic, genetic, and endocrinological causes was started. We 
observed: decreased insulin-like growth factor (IGF-1) (< 15 ng/mL) and growth hormone 
(GH) (0.56 ng/mL); adrenocorticotropic hormone (ACTH) within reference values (15.2 
ng/L, N: < 63.3) and low cortisol (4.5 µg/dL, N: 6.2–19.4), both inappropriately normal in 
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hypoglycaemia; decreased insulin (< 0.2 µU/mL, N: 2.6–24.9) and C-peptide (0.28 ng/mL, 
N: 1.1–4.4); TSH normal (4.23 µUI/ml, N: 3.5 ± 2.6), free-T4 low (0.57 ng/dL, N: 1.5 ± 
0.47). Rhinovirus was detected in bronchial secretions; the study for hepatotropic virus was 
negative. Ammonia, lactate, amino acids, acylcarnitines, organics acid, and succinyl acetone 
were normal or unremarkable. Brain MRI revealed ectopic neurohypophysis and sella turcica 
without definition, reduced to a thin lamina, with suspected pituitary stalk interruption (Fig. 
2). Panhypopituitarism was confirmed; levothyroxine, hydrocortisone, and somatropin were 
started. No recurrence of hypoglycaemia and progressive normalization of liver function was 
verified.
Hypoglycaemia and cholestatic jaundice may be the first signs of pituitary hormone 
deficiency, but the diagnosis of hypopituitarism may be challenging. Clinical presentation is 
variable, from asymptomatic to a broad spectrum of symptoms, including failure to thrive, 
hypoglycaemia, jaundice, dysmorphic features, such as midline defects, nystagmus, optic 
atrophy, and micropenis, or later with short stature and delayed puberty [1, 3]. These 
symptoms are often assigned in a suspected hepatic or metabolic disease, and the 
endocrinological study is frequently delayed, with severe consequences including death.1
In a previous experience with another case referred to our Gastroenterology Unit, 
severe hypoglycaemia and the signs on transfontanellar ultrasound contributed to the 
suspicion of an endocrine aetiology. The association between non-infectious hepatitis, 
hyperbilirubinaemia, cholestasis, and hypopituitarism has been described [3, 4]. 
Hypoglycaemia, generally serious, can occur in the first days, but less severe episodes
may not manifest until a stressful situation occurs [2]. In our case, the possible relationship 
with rhinovirus infection and fever as a situation that triggered imbalance can be questioned. 
Hypoglycaemia usually resolves with the replacement of GH and/or cortisol, although it may 
occur during stressful periods when it is adequate to double the dose of corticosteroid [5].
Hypopituitarism is confirmed by determination of cortisol, ACTH, and GH in 
hypoglycaemia and other hormones (TSH, T4, prolactin, gonadotropins) under baseline 
conditions and/or by functional tests; brain MRI is the choice of method for definitive 
diagnosis. In our case, the normal newborn screening could be a confounding factor, but we 
must bear in mind that screening for congenital hypothyroidism in Portugal is established by 
measuring the elevation of TSH in newborns, which does not exist in this situation.
Early treatment is crucial to reduce morbidity and prevent progressive hepatic disease 
and neurological complications. It is essential to maintain follow-up in a Paediatric 
Endocrinology consultation.
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We emphasize the importance of a high suspicion index for this condition when an 
infant presents cholestasis, unexplained hepatitis, hypoglycaemia, and other manifestations of
pituitary malfunction.
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Figure 1. Peculiar facies — high forehead, low-set ears that are slightly rotated, broad nasal 
bridge, and retrognathism
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Figure 2. Brain MRI. The arrows point to the sella turcica, reduced to a thin lamina without 
definition, and suspected pituitary stalk interruption
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